Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
2 other identifiers
interventional
1,830
1 country
3
Brief Summary
The purpose of this study is to determine if, among women who were treated for a prior chlamydial infection, home-based, self-collected vaginal swabs can increase rescreening for chlamydia in comparison with rescreening in the clinic. The study design is two randomized trials with enrollment at multiple family planning clinics and sexually transmitted disease (STD) clinics following a common protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2003
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 18, 2005
CompletedFirst Posted
Study publicly available on registry
August 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedJanuary 7, 2010
January 1, 2010
4.9 years
August 18, 2005
January 6, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of women rescreened for chlamydia
Interventions
Eligibility Criteria
You may qualify if:
- Women/girls with a lab-confirmed genital chlamydia infection
You may not qualify if:
- Women who are pregnant, or are trying to conceive in the following 3 months.
- Women who are planning to move in the following 3 months or currently living outside the study areas.
- Inability to understand spoken English adequately to assure informed consent and compliance with study procedures.
- Self-reported HIV infection; other serious illnesses or disability.
- Self-reported allergy to macrolide antibiotics such as azithromycin.
- Referrals from providers or clinics other than the STD or family planning clinics, unless women are re-tested at the STD clinics and test positive for chlamydia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Louisiana State University (LSU) Health Sciences Center
New Orleans, Louisiana, 70112, United States
The Mississippi State Department of Health, Bureau of STD/HIV
Jackson, Mississippi, 39216, United States
Washington University
St Louis, Missouri, 63110, United States
Related Publications (1)
Xu F, Stoner BP, Taylor SN, Mena L, Tian LH, Papp J, Hutchins K, Martin DH, Markowitz LE. Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gynecol. 2011 Aug;118(2 Pt 1):231-239. doi: 10.1097/AOG.0b013e3182246a83.
PMID: 21775837DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fujie Xu
Centers for Disease Control and Prevention
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
Study Record Dates
First Submitted
August 18, 2005
First Posted
August 22, 2005
Study Start
October 1, 2003
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
January 7, 2010
Record last verified: 2010-01